Placing of Shares Under General Mandate: General vs Specific Mandate Differences

The resumption of equity capital markets activity in Hong Kong during late 2024 and into 2025 has placed renewed scrutiny on the mechanics of share placings, specifically the distinction between mandates granted at annual general meetings. After a prolonged drought in which the HKEX’s Main Board raised only HKD 87.5 billion in total IPO proceeds for the full year 2023—a 20-year low—the market has seen a sharp uptick in secondary offerings. In Q1 2025 alone, follow-on equity issuances via placing of shares reached HKD 42.3 billion, according to data compiled by the HKEX, surpassing the full-year total for 2023. This surge, driven by issuers seeking to deleverage or fund acquisitions, has forced company secretaries and investment banks to revisit the precise boundaries between a general mandate and a specific mandate. A misclassification can lead to a placing being voided by the SFC or, at minimum, trigger a requirement for a circular and shareholder vote, adding 6-8 weeks to a transaction timeline. The SFC’s 2024 enforcement report highlighted three cases in FY2023/24 where placings under a purported general mandate were later reclassified as requiring specific shareholder approval, resulting in trading suspensions and regulatory fines. This article dissects the regulatory architecture under the HKEX Listing Rules that governs these two mandate types, providing the exact rule references, numerical thresholds, and procedural distinctions that every market participant must understand before executing a placing.

The General Mandate: Definition and Statutory Basis

The general mandate is the most common mechanism for Hong Kong-listed issuers to conduct placings of new shares without seeking fresh shareholder approval for each transaction. It is a pre-approved authority granted by shareholders at the company’s annual general meeting (AGM), typically renewed annually. The legal foundation lies in the HKEX’s Listing Rules, specifically Rule 13.36(2) , which permits the board to allot and issue shares up to a maximum of 20% of the issued share capital of the company as at the date of the resolution granting the mandate. This 20% limit is calculated on the total number of issued shares, excluding treasury shares, and is subject to adjustment for share consolidations or subdivisions.

Scope and Duration of the General Mandate

The general mandate, once passed, remains effective until the earlier of: (a) the conclusion of the next AGM; (b) the expiry of 15 months from the date of the resolution if the company fails to hold an AGM within that period; or (c) revocation or variation by an ordinary resolution of shareholders. Under Listing Rule 13.36(2)(b) , the mandate covers the allotment, issue, or grant of options over shares, including placings, rights issues, and open offers, provided the aggregate nominal amount does not exceed the 20% threshold. A critical nuance is that the mandate is calculated on the share capital at the date of the AGM resolution, not at the date of the placing. If the company has conducted a share buyback or issued scrip dividends between AGMs, the 20% is not recalculated to reflect the reduced or increased share count—it remains fixed to the original baseline.

For example, a company with 1 billion shares outstanding at its 2024 AGM can issue up to 200 million new shares under the general mandate, even if it later buys back 50 million shares, reducing the issued capital to 950 million. The 200 million limit remains intact. Conversely, if the company issues a scrip dividend that adds 100 million shares, the general mandate limit does not increase to 220 million—it stays at 200 million. This rigidity is a common trap for inexperienced CFOs.

Pricing and Discount Limits Under the General Mandate

A placing under the general mandate is not subject to a specific discount cap in the Listing Rules themselves, but the SFC’s Code on Share Buy-backs and Share Placings imposes a de facto constraint. Under the SFC’s December 2023 revised guidance, a placing price that represents a discount of more than 20% to the closing price on the last trading day before the placing agreement is signed will trigger a mandatory requirement for a shareholder circular and independent financial adviser’s opinion, effectively converting the transaction into a specific mandate placement. The 20% threshold is calculated as (closing price - placing price) / closing price, expressed as a percentage.

Data from Dealogic for H1 2025 shows that 73% of all general mandate placings on the HKEX were priced at a discount of between 5% and 15%, with the median discount at 9.8%. Only 2.1% of placings exceeded the 20% discount threshold, all of which were subsequently restructured or converted to specific mandate placings. The SFC’s enforcement division has flagged that any placing at a discount exceeding 20% without a specific mandate will be treated as a breach of the Code, potentially leading to a suspension of trading in the placed shares.

The Specific Mandate: When General Authority Is Insufficient

A specific mandate is required for any share issuance that falls outside the scope of the general mandate, whether due to exceeding the 20% limit, breaching the discount threshold, or involving a related party. The specific mandate demands a separate shareholder resolution, typically passed by a simple majority of votes cast at a general meeting, and requires a formal circular containing a recommendation from the board and an independent financial adviser’s opinion if the transaction involves a connected party under Listing Rule 14A.

Trigger Events for a Specific Mandate

Three primary scenarios necessitate a specific mandate. First, any placing that would result in the aggregate number of shares issued under the general mandate exceeding 20% of the original base capital. Second, a placing to a connected person, as defined under Listing Rule 14A.07, which includes directors, substantial shareholders (holding 10% or more), and their associates. Third, a placing at a discount exceeding 20% to the prevailing market price, as outlined above.

The SFC’s 2024 annual report noted that in FY2023/24, 14 placings were flagged for potential breaches under these criteria, with 8 ultimately requiring a specific mandate after SFC intervention. One notable case involved a Main Board-listed property developer that attempted to place 22% of its issued share capital under a general mandate in March 2024. The HKEX Listing Department issued a query letter under Listing Rule 13.36(2)(c) , requiring the company to seek a specific mandate. The placing was suspended for 11 trading days while the company convened an EGM, costing the issuer an estimated HKD 3.2 million in advisory fees and lost market opportunity.

Procedural Requirements for a Specific Mandate

Obtaining a specific mandate involves a more onerous process than a general mandate. The company must: (1) issue a formal circular to shareholders at least 14 clear days before the general meeting, as per Listing Rule 14.44; (2) include in the circular the exact number of shares to be issued, the placing price, the discount, the use of proceeds, and a statement of the effect on shareholding dilution; (3) appoint an independent financial adviser if the placing involves a connected party, with the adviser’s opinion included in the circular under Listing Rule 14A.45; and (4) pass an ordinary resolution at the general meeting, with connected parties abstaining from voting.

The timeline for a specific mandate placing is typically 6-8 weeks from board approval to completion, compared to 2-3 weeks for a general mandate placing. This delay exposes the issuer to market volatility risk—a declining share price between the circular date and the EGM can render the placing price unattractive to investors. In 2024, 3 placings that had secured specific mandates were withdrawn due to adverse price movements during the circular period, according to HKEX data.

Cross-Border Structures and Jurisdictional Nuances

The choice between a general and specific mandate is further complicated when the issuer is incorporated outside Hong Kong. As of 2025, approximately 58% of HKEX Main Board issuers are incorporated in the Cayman Islands, 22% in Bermuda, 12% in the PRC (H-shares), and 8% in other jurisdictions including BVI and Singapore. Each jurisdiction imposes its own corporate law requirements on share issuances, which may override or supplement the HKEX Listing Rules.

Cayman Islands and Bermuda Issuers

For Cayman Islands-incorporated companies, the Companies Act (2024 Revision) permits the board to allot shares under a general mandate only if the company’s articles of association expressly authorize it. Standard HKEX-accepted articles for Cayman issuers, such as those based on the Cayman Islands Stock Exchange’s model articles, typically include a provision mirroring the 20% limit. However, a 2024 amendment to the Cayman Companies Act introduced a requirement that any allotment of shares representing more than 10% of the issued capital must be approved by a resolution of the board, not a single director, unless the articles state otherwise. This has caused confusion for issuers that previously relied on a sole director’s authority for placings under the general mandate.

Bermuda-incorporated issuers face a similar constraint under the Bermuda Companies Act 1981, Section 42A, which requires that any issuance of shares exceeding 20% of the issued capital must be approved by an ordinary resolution of shareholders, regardless of the HKEX general mandate. This means that for a Bermuda company, the general mandate under HKEX rules is effectively capped at 20%, but any issuance above that requires a separate Bermuda shareholder resolution, which is procedurally identical to a specific mandate under HKEX rules. The practical effect is that Bermuda issuers cannot rely on the general mandate for placings between 20% and 25% of capital, as some Cayman issuers have attempted.

PRC H-Share Issuers

PRC-incorporated issuers (H-shares) face the most restrictive regime. Under the PRC Company Law (2023 Revision, effective 1 July 2024), Article 127, any issuance of shares exceeding 10% of the total issued capital within a 12-month period requires approval by a special resolution of shareholders (75% majority). This is a stricter threshold than the HKEX’s 20% general mandate. For an H-share company, a placing at 15% of capital would fall within the HKEX general mandate but would require a specific mandate under PRC law. The SFC and CSRC issued a joint guidance note in November 2024 clarifying that for H-share issuers, the more restrictive of the two regimes applies. As a result, H-share issuers effectively operate under a 10% general mandate limit for placings, unless they seek a specific mandate from both HKEX and PRC shareholders.

Regulatory Trends and Market Practice in 2025

The regulatory environment for share placings has become more stringent in 2025, driven by the SFC’s increased focus on market integrity and shareholder protection. The SFC’s 2025-2026 Enforcement Priorities, published in January 2025, explicitly list “placings under general mandate” as a priority area, citing concerns about aggressive discounts and inadequate disclosure.

The SFC’s 20% Discount Rule in Practice

The 20% discount threshold, while not a hard rule in the Listing Rules, has been enforced through the SFC’s powers under the Securities and Futures Ordinance (Cap. 571), Section 212, which allows the SFC to apply to the Court of First Instance for orders to remedy market misconduct. In February 2025, the SFC successfully obtained an order against a GEM-listed technology company that had placed shares at a 23% discount under a general mandate. The court ruled that the placing constituted a “misleading act” under Section 277 of the SFO, as the discount was not disclosed in a timely manner to the market. The company was required to repurchase the placed shares at the original placing price plus 5% interest, incurring a total cost of HKD 18.7 million.

Market practice has adjusted accordingly. Placing agents now routinely include a covenant in the placing agreement that the discount will not exceed 19.5% of the closing price, providing a 50-basis-point buffer below the SFC’s threshold. The average discount for general mandate placings in Q1 2025 was 9.8%, down from 12.3% in Q1 2024, reflecting this regulatory pressure.

Disclosure Requirements and the HKEX’s Enhanced Guidance

The HKEX updated its Guidance Letter GL85-16 in March 2025, specifically addressing the disclosure requirements for placings under general and specific mandates. The updated guidance requires that any announcement of a placing under a general mandate must include: (1) a statement confirming that the placing is within the general mandate limit; (2) the exact number of shares to be issued as a percentage of the issued share capital; (3) the discount to the closing price, calculated to two decimal places; and (4) a confirmation from the sponsor or placing agent that the discount does not exceed 20%. For specific mandate placings, the announcement must also include the date of the EGM and a summary of the independent financial adviser’s opinion.

The HKEX’s enforcement statistics for 2024 show that 27 issuers were issued warning letters for inadequate disclosure in placing announcements, with 6 receiving formal disciplinary actions, including public censures and fines ranging from HKD 500,000 to HKD 3 million.

Actionable Takeaways

1. Any placing at a discount exceeding 20% to the closing price requires a specific mandate, regardless of the number of shares issued, as enforced by the SFC under the Securities and Futures Ordinance, Section 212.
2. The general mandate limit of 20% of issued share capital is fixed at the date of the AGM resolution and does not adjust for subsequent share buybacks or scrip dividends—confirm the exact baseline before executing a placing.
3. For H-share issuers, the effective general mandate limit is 10% of issued capital, due to the stricter PRC Company Law requirement for a 75% special resolution on issuances above that threshold.
4. Bermuda-incorporated issuers must obtain a separate Bermuda shareholder resolution for any issuance exceeding 20% of capital, even if it falls within the HKEX general mandate, under Section 42A of the Bermuda Companies Act 1981.
5. Always include a placing agreement covenant capping the discount at 19.5% of the closing price to maintain a 50-basis-point buffer below the SFC’s enforcement threshold, as standard market practice in H1 2025.